|
|
|
|
|
|
|
¾àÇ°°Ë»ö |
|
ºÎÀÛ¿ë ¹× ´ëó¹ý |
|
|
|
|
|
|
|
¸®³Ø½Å¼¹æÁ¤ Renexin CR Tab.
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
¿¬µÎ»öÀÇ Å¸¿øÇü ¼¹æ¼º Çʸ§ÄÚÆÃÁ¤ |
|
|
|
|
|
Á¦Á¶È¸»ç |
¿¡½ºÄÉÀÌÄɹÌÄ®(ÁÖ)
|
ÆǸÅȸ»ç |
¿¡½ºÄÉÀÌÄɹÌÄ®(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2020.03.24)
|
BIT ¾àÈ¿ºÐ·ù |
Ç×Ç÷Àü,Ç÷¼ÒÆÇÀÀÁý¾ïÁ¦Á¦ (Antithrombotics, Antiplatelet Agents)
|
º¹ÁöºÎºÐ·ù |
339[±âŸÀÇ Ç÷¾× ¹× ü¾×¿ë¾à ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
644704780 \1,324 ¿ø/1Á¤(2020.06.01)(ÇöÀç¾à°¡)
|
|
|
ATCÄÚµå |
Platelet aggregation inhibitors excl. heparin / B01AC |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
°æÁú¹«¼ö±Ô»ê,
¶ó¿ì¸±È²»ê³ªÆ®·ý,
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
Å©·Î½ºÆ÷ºñµ·,
Æ÷ºñµ·,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
È÷ÇÁ·Î¸á·Î¿À½º
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-08-14 |
|
|
|
|
|
|
|
|
|